N-[3-(R)-tetrahydrofuranyl]-6-aminopurine riboside, an A1 adenosine receptor agonist, antagonizes catecholamine-induced lipolysis without cardiovascular effects in awake rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 1, 2003, Pages 225-231

  Fraser, Heather ^a   Gao, Zhenhai ^a   Ozeck, Mark J ^a   Belardinelli, Luiz ^a  

^a CV THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR AGONIST; CATECHOLAMINE; FATTY ACID; NORADRENALIN; PALMITIC ACID; TECADENOSON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; FATTY ACID BLOOD LEVEL; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; ISOLATED HEART; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ADENOSINE; ADIPOCYTES; ANIMALS; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; DRUG INTERACTIONS; FATTY ACIDS; FURANS; HEART; LIPOLYSIS; MALE; MYOCARDIUM; NOREPINEPHRINE; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1;

EID: 0037382360     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.046821     Document Type: Article

References (41)

1. Altman PL and Dittmer DS (1971) Respiration and Circulation. Federation of American Societies for Experimental Biology, Bethesda, MD.
2. Belardinelli L, Linden J, and Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97.
3. Belardinelli L, Shryock JC, Zhang Y, Scammells PJ, Olsson R, Dennis D, Milner P, Pfister J, and Baker SP (1995) 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells. J Pharmacol Exp Ther 275:1167-1176.
4. Collis MG and Hourani SM (1993) Adenosine receptor subtypes. Trends Pharmacol Sci 14:360-366.
5. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, and Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461-1468.
6. Dobson JG Jr, Fenton RA, and Romano FD (1987) The cardiac anti-adrenergic effect of adenosine. Prog Clin Biol Res 230:331-343.
7. Dong Q, Ginsberg HN, and Erlanger BF (2001) Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance. Diabetes Obes Metab 3:360-366.
8. Fraser H, Lopaschuk GD, and Clanachan AS (1999) Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation. Br J Pharmacol 128:197-205.
9. Fresco P, Diniz C, Queiroz G, and Goncalves J (2002) Release inhibitory receptors activation favours the A(2A)-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery. Br J Pharmacol 136:230-236.
10. Gao Z, Robeva AS, and Linden J (1999) Purification of A1 adenosine receptor-G-protein complexes: effects of receptor down-regulation and phosphorylation on coupling. Biochem J 338:729-736.
11. Henderson AH, Craig RJ, Gorlin R, and Sonnenblick EH (1970) Free fatty acids and myocardial function in perfused rat hearts. Cardiovasc Res 4:466-472.
12. Hirvonen J, Huttunen P, Nuutinen L, and Pekkarinen A (1978) Catecholamines and free fatty acids in plasma of patients undergoing cardiac operations with hypothermia and bypass. J Clin Pathol 31:949-955.
13. Hoffman BB, Chang H, Dall'Aglio E, and Reaven GM (1986) Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes. J Clin Invest 78:185-190.
14. Hutter JF, Piper HM, and Spieckerman PG (1985) Effect of fatty acid oxidation on efficiency of energy production in rat heart. Am J Physiol 249:H723-H728.
15. Kalman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, and Tonkin AM (1995) Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60:1709-1715.
16. Kurien VA, Yates PA, and Oliver MF (1971) The role of free fatty acids in the production of ventricular arrhythmias after acute coronary artery occlusion. Eur J Clin Invest 1:225-241.
17. Liang HX, Belardinelli L, Ozeck MJ, and Shryock JC (2002) Tonic activity of the rat adipocyte A1-adenosine receptor. Br J Pharmacol 135:1457-1466.
18. Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, and Allard MF (2001) Regulation of myocardial fatty acid oxidation by substrate supply. Am J Physiol Heart Circ Physiol 281:H1561-H1567.
19. Lopaschuk GD, Collins-Nakai R, Olley PM, Montague TJ, McNeil G, Gayle M, Penkoske P, and Finegan BA (1994) Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 128:61-67.
20. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, and Braunwald E (1971) Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43:67-82.
21. Merkel LA, Hawkins ED, Colussi DJ, Greenland BD, Smits GJ, Perrone MH, and Cox BF (1995) Cardiovascular and antilipolytic effects of the adenosine agonist GR79236. Pharmacology 51:224-236.
22. Mjos OD, Kjekshus JK, and Lekven J (1974) Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs. J Clin Invest 53:1290-1299.
23. Neely JR and Morgan HE (1974) Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36:413-459.
24. Oliver MF (2001a) Antilipolytic drugs for the prevention of primary ventricular fibrillation. Diabetes Obes Metab 3:61-65.
25. Oliver MF (2001b) Prevention of ventricular fibrillation during acute myocardial ischemia: control of free fatty acids. J Cardiovasc Pharmacol Ther 6:213-217.
26. Oliver MF and Kurien VA (1969) Serum-free-fatty-acids and arrhythmias after acute myocardial infarction. Lancet 2:1077-1078.
27. Opie LH (1988) Sympathetic stimulation of ischemic myocardium: role of plasma free fatty acids and potassium. J Cardiovasc Pharmacol 12 (Suppl 1):S31-S38.
28. Opie LH (1998) The Heart: Physiology, from Cell to Circulation, pp 295-342, Lippincott Williams & Wilkins, Philadelphia.
29. Opie LH, Tansey M, and Kennelly BM (1977) Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma-free-fatty-acid concentrations. Lancet 2:890-892.
30. Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380.
31. Schenkman KA (2001) Cardiac performance as a function of intracellular oxygen tension in buffer-perfused hearts. Am J Physiol Heart Circ Physiol 281:H2463-H2472.
32. Shryock JC and Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology. Am J Cardiol 79:2-10.
33. Simonsen S and Kjekshus JK (1978) The effect of free fatty acids on myocardial oxygen consumption during atrial pacing and catecholamine infusion in man. Circulation 58:484-491.
34. Snowdy S, Liang HX, Blackburn B, Lum R, Nelson M, Wang L, Pfister J, Sharma BP, Wolff A, and Belardinelli L (1999) A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig. Br J Pharmacol 126:137-146.
35. Srinivas M, Shryock JC, Dennis DM, Baker SP, and Belardinelli L (1997) Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes. Mol Pharmacol 52:683-691.
36. Stanley WC, Lopaschuk GD, Hall JL, and McCormack JG (1997) Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33:243-257.
37. Strong P, Anderson R, Coates J, Ellis F, Evans B, Gurden MF, Johnstone J, Kennedy I, and Martin DP (1993) Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236. Clin Sci (Lond) 84:663-669.
38. Tatsis-Kotsidis I and Erlanger BF (1999) A1 adenosine receptor of human and mouse adipose tissues: cloning, expression and characterization. Biochem Pharmacol 58:1269-1277.
39. 6-(p-sulphophenyl)adenosine in rats. Br J Pharmacol 122:525-533.
40. Wu L, Belardinelli L, Zablocki JA, Palle V, and Shryock JC (2001) A partial agonist of the A(1)-adenosine receptor selectively slows AV conduction in guinea pig hearts. Am J Physiol Heart Circ Physiol 280:H334-H343.
41. Zannikos PN, Rohatagi S, and Jensen BK (2001) Pharmacokinetic-pharmacodynamic modeling of the antilipolytic effects of an adenosine receptor agonist in healthy volunteers. J Clin Pharmacol 41:61-69.